Eris Lifesciences Limited

Eris Lifesciences Limited
Law Firms NewsNews

DEAL DETAILS

Eris Lifesciences Limited | Acquisition of the Indian branded formulations business of Biocon Biologics Limited

Khaitan & Co advised Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India for a total consideration of INR 1,242 Crores. The acquisition helps augment and expand the business of Eris Lifesciences in the branded sterile injectibles market and enter into the oncology and critical care segments in India. As part of this deal, Eris Lifesciences Limited has also signed a 10-year supply agreement with Biocon Biologics Limited.

The team was led by Kalpana Unadkat (Partner) with assistance from Kevin Shah (Principal Associate), and Sushmita Som (Associate).

The Firm acted as legal counsel for Eris Lifesciences Limited and assisted in drafting, reviewing, negotiating and finalising the transaction documents.

Eris Lifesciences Limited
Law Firms NewsNews

Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (“Eris”) on the acquisition of a majority stake in Swiss Parenterals Limited (“SPL”) from the existing shareholders of SPL by Eris and certain individual purchasers. The aggregate deal value is approximately INR 875 Crores (USD 105.38 million). The consideration was paid through a combination of cash consideration and issuance by Eris of secured, redeemable non-convertible debentures.

After completion of the transaction, Eris holds 51% of the share capital of SPL and the individual purchasers, collectively, hold ~19% of the share capital of SPL.

The transaction augments the capability of Eris in the sterile injectables segment.

The transaction team was led by Nivedita Tiwari, Partner; Devesh Pandey, Partner; Shailesh Singh, Principal Associate; and Anushka Ganguli, Associate.

The financing team was led by Shilpa Mankar Ahluwalia, Partner; Shubhangi Garg, Partner; Utsav Dubey, Principal Associate; Purva Anand, Associate; and Gunjan Shrivastav, Associate.

Tax team was led by Gouri Puri, Partner and Rahul Yadav, Counsel.

Ritwik Bhattacharya, Partner advised on the competition law aspects.

SPL and the Sellers were advised by Cyril Amarchand Mangaldas on the legal aspects.

About Shardul Amarchand Mangaldas & Co:

Shardul Amarchand Mangaldas & Co., founded on a century of legal achievements, is one of India’s leading full-service law firms. The Firm’s mission is to enable business by providing solutions as trusted advisers through excellence, responsiveness, innovation, and collaboration. SAM & Co. is known globally for its exceptional practices in mergers & acquisitions, private equity, competition law, insolvency & bankruptcy, dispute resolution, international commercial arbitration, capital markets, banking & finance, tax, intellectual property, data protection and data privacy, technology law and projects & infrastructure.

The Firm has a pan-India presence and has been at the helm of major headline transactions and litigations in all sectors, besides advising major multinational corporates on their entry into the Indian market and their business strategy. Currently, the Firm has over 824 lawyers including 165 Partners, offering legal services through its offices in New Delhi, Mumbai, Gurugram, Ahmedabad, Kolkata, Bengaluru, and Chennai.

Eris Lifesciences Limited
Law Firms NewsNews

Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (“Eris”) on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited (“Biocon”) in India. The deal is valued at approximately INR 366 crores and the date of closing the deal was 10 November 2023.

This acquisition marks the entry of Eris into Nephrology, and also enables Eris to consolidate its position in Dermatology.

The transaction team was led by Nivedita Tiwari, Partner; Shailesh Singh, Principal Associate; and Anupama Singh, Senior Associate.

The employment law team was led by Pooja Ramchandani, Partner, and Suruchi Kumar, Principal Associate.

The IP law team was led by Apoorva Murali, Partner; and Neha Khanduri, Senior Associate.

The tax team was led by Amit Singhania, Partner; Ankita Bhasin, Counsel; Rahul Yadav, Counsel; and Mansie Jain, Associate.

The competition law team was led by Harman Singh Sandhu, Partner; Raveena Kumari Sethia, Senior Associate; and Abhishek Hazari, Associate.

Cyril Amarchand Mangaldas advised Biocon.

About Shardul Amarchand Mangaldas & Co:

Shardul Amarchand Mangaldas & Co., founded on a century of legal achievements, is one of India’s leading full-service law firms. The Firm’s mission is to enable business by providing solutions as trusted advisers through excellence, responsiveness, innovation, and collaboration. SAM & Co. is known globally for its exceptional practices in mergers & acquisitions, private equity, competition law, insolvency & bankruptcy, dispute resolution, international commercial arbitration, capital markets, banking & finance, tax, intellectual property, data protection and data privacy, technology law and projects & infrastructure.

The Firm has a pan-India presence and has been at the helm of major headline transactions and litigations in all sectors, besides advising major multinational corporates on their entry into the Indian market and their business strategy. Currently, the Firm has over 822 lawyers including 166 Partners, offering legal services through its offices in New Delhi, Mumbai, Gurugram, Ahmedabad, Kolkata, Bengaluru, and Chennai.